Equities

Microbix Biosystems Inc

MBX:TOR

Microbix Biosystems Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.34
  • Today's Change-0.005 / -1.45%
  • Shares traded5.00k
  • 1 Year change+15.25%
  • Beta0.3623
Data delayed at least 15 minutes, as of Sep 20 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Sep 30 2023202320222021
ASSETS
Cash And Short Term Investments12139.99
Total Receivables, Net4.183.094.21
Total Inventory5.755.284.41
Prepaid expenses0.770.550.50
Other current assets, total------
Total current assets222219
Property, plant & equipment, net8.938.918.08
Goodwill, net------
Intangibles, net4.421.501.65
Long term investments------
Note receivable - long term------
Other long term assets00.33--
Total assets363329
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.270.272.66
Other current liabilities, total2.000.550.74
Total current liabilities4.352.655.19
Total long term debt6.385.565.08
Total debt6.655.827.74
Deferred income tax------
Minority interest------
Other liabilities, total0.30----
Total liabilities118.2110
SHAREHOLDERS EQUITY
Common stock495044
Additional paid-in capital109.6211
Retained earnings (accumulated deficit)(37)(37)(39)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total2.272.272.90
Total equity252519
Total liabilities & shareholders' equity363329
Total common shares outstanding137139126
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.